Biosimilar nomenclature: Deadline August 2 for comments on FDA’s OMB information request
Meaningful suffix may be in for U.S. biologics, biosimilars FDA Pushes Back Comment Period for Biosimilar Labeling Just released: new deadline August?2 for information collection requ…
